Targagenix, Inc.
- UEI
- GZKVUPMHUBF3
- CAGE
- 76GC1
- Primary NAICS
- 325411 Medicinal and Botanical Manufacturing
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Website
- targagenix.com
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| R & d- nanoemulsion formulation and IND-enabling studies of a novel center stem cell cytotoxic agent | National Cancer Institute (NIH) | $2,284,577 |
Quick answers
Is Targagenix, Inc. registered in SAM.gov?
Targagenix, Inc.'s SAM.gov registration expired on November 2, 2019.
What is Targagenix, Inc.'s most recent federal award?
Targagenix, Inc.'s most recent federal contract award is R & d- nanoemulsion formulation and IND-enabling studies of a novel center stem cell cytotoxic agent (HHSN261201500018C), from National Cancer Institute (NIH), on September 22, 2015.
On GovTribe
See Targagenix, Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors